Funding opportunities
Open and upcoming programs from Canadian funders and US federal grants (Grants.gov). Deadlines first, then rolling intakes.
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)
National Institutes of Health · Deadline 2027-05-07
The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty.
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)
National Institutes of Health · Deadline 2027-05-07
The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty.
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
National Institutes of Health · Deadline 2027-05-07
The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICOs) are issuing this notice of funding opportunity (NOFO) seeking applications to test innovative approaches to implementing SBIRT/P for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities. SBIRT/P, (a term used for purposes of this funding announcement), involves screening individuals for risk of ATOD use and misuse, briefly intervening with a conversation about harmful substance use, and referring individuals for treatment or preventive services, as needed. Proposed research should include prospective tests of SBIRT/P and should leverage collaborations with healthcare and community partners. Specific research interests of participating NIH ICOs are detailed within.
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
National Institutes of Health · Deadline 2027-05-07
The purpose of this funding opportunity is to encourage multidisciplinary investigators to submit applications developing exploratory, highly novel new approaches, or innovative applications of existing approaches to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease, by improving repeated measures across longer epochs of the lifespan to better predict outcomes at later ages. . Research can include healthy human participants of any age, specific clinical groups such those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation through this high risk, high reward funding mechanism to develop highly innovative ideas that either l
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
National Institutes of Health · Deadline 2027-05-07
The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease. Research can include healthy human participants of any age, specific clinical groups such as those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation to improve repeated measures across longer epochs of the lifespan, to better predict outcomes at later ages.
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
National Institutes of Health · Deadline 2027-05-07
This Notice of Funding Opportunity (NOFO) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions. Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an evidence base. This NOFO provides resources for assessing the feasibility, acceptability, and utility of these approaches, in addition to usual trial preparation activities.
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
National Institutes of Health · Deadline 2027-05-08
The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
National Institutes of Health · Deadline 2027-05-08
The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
National Institutes of Health · Deadline 2027-05-08
The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)
National Institutes of Health · Deadline not published
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) through a single U24 cooperative agreement award. The NOFO will be open to all eligible applicants. Established in 2022, the EL DMCC serves as the central hub for NIA’s human longevity translational research portfolio, integrating data and activities across studies to maximize the value of deeply phenotyped cohorts and associated genomic and multi-omics datasets. The DMCC currently plays a critical role in enabling cross-cohort analyses, coordinating collaborative research, and advancing shared data resources. Core functions include data harmonization and integration; development and implementation of common data standards; provision of statistical, computational, and artificial intelligence and machine learning (AI/ML) infrastructure and tools; coordination of cross-project collaborations; and managing shared data systems, including data storage, access, and platform operations. The DMCC also develops and maintains the ELITE (Exceptional Longevity Translational
National Center on Elder Abuse Resource Center
Administration for Community Living · Deadline not published
This cooperative agreement is to operate the National Center on Elder Abuse (NCEA) with the purpose to improve national, state, and local communities' preparation to prevent, identify, and intervene in elder abuse, neglect, and exploitation so that older Americans can live with dignity, integrity, and independence. The NCEA achieves this by providing web-based, downloadable, and in-person information, resources, and training to professionals and the public on best practices for preventing and responding to elder abuse, neglect, and exploitation so that professionals and the public are better informed about elder maltreatment, frauds, and scams and are better able to avoid or stop them. Awards range from $856,250 to $1,000,000.
FY2027 Grants to Highest State Courts to Improve Guardianship
Administration for Community Living · Deadline not published
The purpose of the EJIG program is to support the development and advancement of new and emerging approaches to address issues related to elder justice. For this opportunity, awards will be made to the highest state courts to improve guardianship by: assessing the fairness, effectiveness, timeliness, safety, integrity, and accessibility of adult guardianship and conservatorship proceedings; implementing changes deemed necessary as a result of the assessments; and/or implementing systems to simplify the filing process for conservators and guardians and better enable courts to identify discrepancies and detect fraud and the exploitation of protected person. Awards range from $200,000 to $500,000.
Elder Justice Innovation Grants FY2027
Administration for Community Living · Deadline not published
The purpose of the EJIG program is to support the development and advancement of new and emerging approaches to issues related to elder justice. Funded projects will contribute to the improvement of the field of elder abuse prevention and intervention by developing materials, programs, etc. that can be widely disseminated and/or replicated, or by establishing and/or contributing to the evidence-base of knowledge. Awards range from $250,000 to $500,000.
National Adult Protective Services Training Center
Administration for Community Living · Deadline not published
This funding opportunity will award one cooperative agreement to operate a National APS Training Center (NATC) to build the capacity of adult protective services professionals and improving the organizations that recruit, train, supervise, manage, and retain them, with the goal of improving the safety and well-being of those experiencing adult maltreatment. The NATC will create various modes of on-line learning and deliver via a web-baed learning management system training for APS workers that promote evidence-informed practice, support leadership development, and improve APS agency organization, culture and climate. Awards range from $1,000,000 to $1,250,000.
IDeA Networks of Biomedical Research Excellence (INBRE)
National Institutes of Health · Deadline not published
The Institutional Development Award program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Networks of Biomedical Research Excellence (INBRE) Notice of Funding Opportunity will support statewide networks in IDeA states made up of one or more research intensive institution and multiple primarily undergraduate institutions. INBREs build biomedical research capacity through supporting faculty research and research mentoring, student participation in research, and enhancement of institutional research infrastructure with an emphasis on developing pathways for undergraduate students in these states to move into biomedical research careers. The INBREs promote collaboration among institutions in IDeA states, create economies of scale, and develop research support capabilities at the primarily undergraduate institutions.
DHQP Global NOFO
Centers for Disease Control - NCEZID · Deadline not published
The proposed international hybrid Notice of Funding Opportunity (NOFO) will link non-research implementation with targeted research that advances CDC's mission to address antimicrobial resistance (AR) across multiple bacterial and fungal pathogens, healthcare-associated infections (HAIs), and emerging infectious disease threats including viral pathogens across healthcare, community, and environmental settings in low and middle-income countries. AR and HAI remain urgent global threats, with substantial mortality and economic impact. Building on CDC's Global AR Laboratory and Response Network, HAI surveillance and prevention networks, and other collaborating programs, the NOFO seeks to strengthen detection, surveillance, prevention, and response systems to reduce illness and death, stop the spread of AR, protect healthcare workers and patients, and lower costs through robust infection prevention and control (IPC) and antimicrobial stewardship.
Asthma and Allergic Diseases Cooperative Research Centers
National Institutes of Health · Deadline not published
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the continued support of the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC). The AADCRC program serves as the cornerstone of NIAID's efforts to promote clinical and basic research in diseases including asthma, upper airway allergic/inflammatory diseases, food and drug allergies, atopic dermatitis, and other allergic diseases. The overarching goals of this program are to investigate mechanisms underlying the onset, progression, treatment modalities, and mechanisms of treatment response for the diseases of interest. Goals of the program may include exploring disease mechanisms and/or treatment modalities in small clinical trials/observational studies or immune pathway-focused projects using primarily human materials. The AADCRC is the only NIAID program that is designed to promote multi-center, multidisciplinary, translational research in asthma and allergic diseases. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42
Translational Transplantation Tolerance Cooperative Study Group
National Institutes of Health · Deadline not published
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the support of the Translational Transplantation Tolerance Cooperative Study Group (TTTCSG) program. The overarching goal of this program is to facilitate clinical translation of safe and effective transplant tolerance regimens that achieve long-term graft survival without the need for life-long administration of immunosuppressive drugs. This program will enable establishment of a multi-center, cooperative program dedicated to developing, optimizing, and evaluating approaches to induce and maintain immune tolerance to allogeneic transplants, which will be tested in translationally relevant models. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Direct-to-Consumer Distribution of HIV and other STI Self-Tests
Centers for Disease Control - NCHHSTP · Deadline not published
The purpose of this notice of funding opportunity (NOFO) is to optimize the recipient's existing web-based ordering portal and distribution program to provide at least 1.5 million HIV and other STI self-tests to communities with a high burden of HIV. The use of the program's HIV and other STI self-tests and of resources for treatment and preventive services will increase awareness of HIV and other STI infection, prevent new infections, decrease HIV and other STI transmission, and improve overall health and well-being of users.
Strengthening Collaboration Between Tuberculosis Control Programs and Affiliated Partners in the United States.
Centers for Disease Control - NCHHSTP · Deadline not published
The Centers for Disease Control and Prevention announces the availability of funding to support one recipient to build on the work under the previous notice of funding opportunity (CDC-RFA-PS22-2205) by strengthening collaboration and relationships with TB control programs, TB controllers, and affiliated partners in the United States. These partners include, but are not limited to, national TB control programs, other federal agencies, academia, businesses, community-based organizations, faith-based organizations, advisory boards, committees, and other entities with an interest in working with key partners in the field to advance CDC Division of Tuberculosis Elimination's mission to promote health and quality of life by preventing, controlling, and eventually eliminating TB in the United States.